Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsight Platform that help ...

Illumina, Inc. introduced three early-access capabilities on its BioInsight Platform that help researchers move faster from sequencing data to discovery. BioInsight Platform Workflow Orchestrator ...

Newly ASX-listed Identifai Genetics plans to launch its AI enabled Windrose pre-natal genetic testing platform in the US within months. ... Read More The post Dr Boreham’s Crucible: Identifai brings a ...

Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Have you ever come across the term "NGS" in articles about cancer gene panel testing or whole-genome analysis?NGS is a technology that reads DNA base sequences in large quantities.While conventional ...

Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...

Building on the momentum from the first half of the year, dealmaking in the life sciences space remained robust in the third quarter of 2026.

A genomic study of small Apollo butterflies in three central Swiss Alpine valleys found no detectable genetic separation, ...

Deep in the mist-shrouded montane forests of Yunnan Province, southwestern China, an insect collector walking along a ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

The Nasdaq rallies Wednesday as SpaceX stock surges on earnings. Meta Platforms and Tesla post earnings late.